Larimar Therapeutics
LRMR
LRMR
94 hedge funds and large institutions have $153M invested in Larimar Therapeutics in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
50% less capital invested
Capital invested by funds: $304M → $153M (-$151M)
85% less call options, than puts
Call options by funds: $5K | Put options by funds: $34K
Holders
94
Holding in Top 10
2
Calls
$5K
Puts
$34K
Top Buyers
| 1 | +$6.93M | |
| 2 | +$2.35M | |
| 3 | +$1.02M | |
| 4 |
Morgan Stanley
New York
|
+$962K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$765K |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.75M | |
| 3 | -$1.75M | |
| 4 |
KC
Kepos Capital
New York
|
-$978K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$894K |